ISSN 2639-9431
Vol. 3, Issue 2, 2020June 27, 2020 EDT
Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products
Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products
Blanka Halamoda-Kenzaoui, Helen Box, Merel van Elk, Sandra Gaitan, Robert E. Geertsma, Eusebio Gainza Lafuente, Andrew Owen, Angel del Pozo, Matthias Roesslein, Susanne Bremer-Hoffmann,
Articles in Vol. 3, Issue 2, 2020
Vol. 3, Issue 2, 2020
- Precision COVID-19 Vaccine with Companion DiagnosticsJulianna LisziewiczFranco Lori
- Thymoquinone: shield and sword against SARS-CoV-2Andrei P. SommerHorst-Dieter FörsterlingKurt G. Naber
- Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health productsBlanka Halamoda-KenzaouiHelen BoxMerel van ElkSandra GaitanRobert E. GeertsmaEusebio Gainza LafuenteAndrew OwenAngel del PozoMatthias RoessleinSusanne Bremer-Hoffmann
- Elevated circulating endothelin-1 as a potential biomarker for high-risk COVID-19 severityZ Shadi FarhangraziS Moein Moghimi
- Enhancing the Development of Therapeutics against SARS-CoV-2 by Exploring the Properties of Therapeutic Nano-structuresRodney Hill
- Recent Advances of Nanocarriers for Effective Delivery of Therapeutic PeptidesMona Atabakhshi-KashiMarzieh GeranpayehvagheiYazhou WangHamidreza AkhbariyoonMohammad TalebYinlong ZhangKhosro KhajehGuangjun Nie
- Latest advances in combining gold nanomaterials with physical stimuli towards new responsive therapeutic and diagnostic strategiesDania MoviaMaroua BenhaddadaJolanda SpadavecchiaAdriele Prina-Mello
- Toll like receptors agonists-based nanomedicines as veterinary immunotherapiesFederico L ParraMaría J MorillaEder L Romero
Halamoda-Kenzaoui, Blanka, Helen Box, Merel van Elk, Sandra Gaitan, Robert E. Geertsma, Eusebio Gainza Lafuente, Andrew Owen, Angel del Pozo, Matthias Roesslein, and Susanne Bremer-Hoffmann. 2020. “Launching Stakeholder Discussions on Identified Regulatory Needs for Nanotechnology-Enabled Health Products.” Precision Nanomedicine 3 (2): 608–21. https://doi.org/10.33218/001c.13521.